Details
APOE (apolipoprotein E) is a plasma protein implicated in lipid metabolism. It is produced predominantly by hepatocytes, macrophages, and neural cells. In the CNS, APOE is the major extracellular lipid carrier and plays a key role in neuronal protection and repair after injury. APOE is polymorphic, with three major alleles: APOE2 (cys112, cys158), APOE3 (cys112, arg158), and APOE4 (arg112, arg158). APOE2 plays a protective role against both Alzheimer's (AD) and heart disease. APOE4 confers a higher risk for atherosclerosis and Alzheimer's disease. Analysis of cerebrospinal fluid (CSF) and plasma APOE protein levels in AD patients had been performed to examine its association with AD pathology. In old age, high plasma APOE levels precede an increase of circulating CRP and strongly associates with cardiovascular mortality.
An anti-tag antibody is pre-coated onto the bottom of wells. After adding antigen or samples, Tagged-Capture antibody and HRP-conjugated detection antibody, a sandwich complex is formed in the solution. TMB acts as a HRP substrate, and the solution color will change from colorless to blue. A stop solution containing sulfuric acid turns the solution yellow. The color intensity is proportional to the quantity of bound protein, which is measurable at 450 nm with the correction wavelength set at 630 nm.
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested 8 times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested in 16 separate assays to assess inter-assay precision.
Intra-assay Precision
| Sample | n | Mean (ng/mL) | SD | CV% |
| 1 | 8 | 5.39 | 0.44 | 8.16 |
| 2 | 8 | 1.34 | 0.04 | 2.99 |
| 3 | 8 | 0.39 | 0.01 | 2.56 |
Inter-assay Precision
| Sample | n | Mean (ng/mL) | SD | CV% |
| 1 | 16 | 5.37 | 0.40 | 7.45 |
| 2 | 16 | 1.34 | 0.08 | 5.97 |
| 3 | 16 | 0.40 | 0.02 | 5.00 |
The recovery of human APOE spiked to three different levels throughout the range of the assay was evaluated.
| Sample Type | Average% of Expected | Range (%) | |
| Human plasma | 1:16,000 | 97 | 93-100 |
| 1:32,000 | 100 | 99-102 | |
| Cell culture supernatant | 1:80 | 98 | 83-112 |
| Urine | 1:8 | 110 | 107-114 |
| 1:16 | 113 | 110-116 | |
| Saliva | 1:8 | 124 | 118-128 |
| 1:16 | 116 | 115-118 | |
| CSF | 1:1,600 | 116 | 99-126 |
To assess the linearity of the assay, samples were diluted with the appropriate Sample Diluent to produce samples with values within the dynamic range of the assay. (The human plasma was initially diluted 1:2,000. The cell culture supernatant was initially diluted 1:20. The CSF was initially diluted 1:200. )
| Human plasma(Sample DiluentPT 4B1) | Cell culturesupernatant(Sample DiluentPT 6) | Urine(Sample DiluentPT 4B1) | Saliva(Sample DiluentPT 4B1) | CSF(Sample DiluentPT 4B1) | ||
| 1:2 | Average% ofExpected | 100 | 100 | 100 | 100 | 100 |
| Range (%) | - | - | - | - | - | |
| 1:4 | Average% ofExpected | 87 | 85 | 101 | 101 | 91 |
| Range (%) | 86-88 | 84-86 | 100-101 | 94-107 | 82-100 | |
| 1:8 | Average% ofExpected | 82 | 76 | 104 | 96 | 90 |
| Range (%) | 82-83 | 75-77 | 97-112 | 83-109 | 81-98 | |
| 1:16 | Average% ofExpected | 79 | 73 | 87 | 91 | 83 |
| Range (%) | 76-81 | 72-74 | 86-88 | 73-110 | 81-85 |
This immunoassay is calibrated against a highly purified recombinant human APOE produced at Sunlong Medical™.
Ordering & shipping
Citations
Partial purchase records (0)
Leave a message
+86 0571 56623320
[email protected]
+86 18668110335

Scan Wechat Qrcode
